Understanding the journey to an IBD diagnosis is key to unlocking early intervention. This detailed infographic breaks down "Pre IBD," the crucial preclinical phase where biological changes begin long before symptoms appear. From genetic predisposition to molecular initiation and subclinical inflammation, the path to Crohn’s disease or ulcerative colitis often spans years. Recognizing these early stages opens the window for prediction, risk stratification, and potentially interception. Dive into the science behind the "At Risk" phase, microbiome shifts, and disease-specific signals. linkedin.com/posts/ibd-libra…

As gastroenterologists, we need to move past the outdated idea that IBD is only a disease of undernutrition. 📊 The evidence is clear: Obesity increases the risk of Crohn’s disease It is associated with more active disease and poorer outcomes It may reduce response to therapy And it increases surgical risk Visceral fat—especially mesenteric fat—is biologically active and can fuel intestinal inflammation. This has real implications for how we counsel patients, dose therapies, and design multidisciplinary care models. 💡 Obesity in IBD is not a failure—it’s a modifiable risk factor and an opportunity to improve outcomes. Proud to share this educational work through IBD Library™. @saia_gi @CrohnsColitisFn @CrohnsColitisUK @aboutIBD @getgutsycanada @gastrogirl @AmCollegeGastro @AmerGastroAssn linkedin.com/posts/ibd-libra…